Description of the Business
For a description of the business see: About ReNeuron
Directors and Committees
For information about the board see: Board of Directors
For information about the responsibilities of the directors and any committees see: Corporate Governance
Country of Incorporation and Main Country of Operation
For details of ReNeuron’s country of incorporation and main country of operation see: About ReNeuron
Current Constitution Documents
To view current constitution documents see: Documents and Circulars
Securities in Issue
For information about number of securities in issue and the percentage of AIM securities not in public hands, together with the identity and percentage of significant shareholders see: Major Shareholdings
The Company is not listed on any other exchanges or trading platforms.
There are no restrictions on the transfer of the Company’s securities.
The Company is subject to the UK City Code on Takeovers and Mergers.
For the most recent annual and interim reports see: Financial Reports
To see recent and historic regulatory announcements see: RNS Announcements
For ReNeuron’s Admission Document see: Documents and Circulars
To see details of the Company’s advisors see: Advisors
This section of the website, and the information that can be accessed from this page, was last updated to comply with Rule 26 on: 13 November 2018